Axcynsis Therapeutics (formerly known as Tetris Therapeutics) is a platform-based biotechnology company focusing on the development of antibody-drug conjugate (ADC) therapies. It develops a pipeline of ADC candidates to address unmet medical needs. The company provides antibody discovery technology, "LP" technology, and conjugation technology.